Human Gene ABL1 (ENST00000318560.6_7) from GENCODE V47lift37
  Description: ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant a (from RefSeq NM_005157.6)
Gencode Transcript: ENST00000318560.6_7
Gencode Gene: ENSG00000097007.20_15
Transcript (Including UTRs)
   Position: hg19 chr9:133,710,641-133,763,062 Size: 52,422 Total Exon Count: 11 Strand: +
Coding Region
   Position: hg19 chr9:133,710,834-133,761,070 Size: 50,237 Coding Exon Count: 11 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:133,710,641-133,763,062)mRNA (may differ from genome)Protein (1130 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: ABL1_HUMAN
DESCRIPTION: RecName: Full=Tyrosine-protein kinase ABL1; EC=2.7.10.2; AltName: Full=Abelson murine leukemia viral oncogene homolog 1; AltName: Full=Abelson tyrosine-protein kinase 1; AltName: Full=Proto-oncogene c-Abl; AltName: Full=p150;
FUNCTION: Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage- induced apoptosis. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine- phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.
CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
COFACTOR: Magnesium or manganese.
ENZYME REGULATION: Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N- terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Also stimulated by cell death inducers and DNA-damage. Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits also the tyrosine kinase activity (By similarity). Inhibited by ABI1, whose activity is controlled by ABL1 itself through tyrosine phosphorylation. Also inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML), and by VX-680, an inhibitor that acts also on imanitib-resistant mutants.
SUBUNIT: Interacts with SORBS1 following insulin stimulation. Found in a trimolecular complex containing CDK5 and CABLES1. Interacts with CABLES1 and PSTPIP1. Interacts with ZDHHC16, ITGB1 and HCK (By similarity). Interacts with INPPL1/SHIP2. Interacts with the 14-3-3 proteins, YWHAB, YWHAE, YWHAG, YWHAH, SFN AND YWHAZ; the interaction with 14-3-3 proteins requires phosphorylation on Thr-735 and, sequesters ABL1 into the cytoplasm. Interacts with ABI1, ABI2, BCR, CRK, FGR, FYN, HCK, LYN, PSMA7 RAD9A, RAD51, RAD52, TP73 and WASF3. A complex made of ABL1, CTTN and MYLK regulates cortical actin-based cytoskeletal rearrangement critical to sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement.
INTERACTION: Q8IZP0:ABI1; NbExp=3; IntAct=EBI-375543, EBI-375446; Q14315:FLNC; NbExp=2; IntAct=EBI-375543, EBI-489954; Q92918:MAP4K1; NbExp=2; IntAct=EBI-375543, EBI-881; P16333:NCK1; NbExp=2; IntAct=EBI-375543, EBI-389883; O43900:PRICKLE3; NbExp=2; IntAct=EBI-375543, EBI-1751761; Q86UR5:RIMS1; NbExp=2; IntAct=EBI-375543, EBI-1043236; Q13671:RIN1; NbExp=4; IntAct=EBI-375543, EBI-366017; P31947:SFN; NbExp=2; IntAct=EBI-375543, EBI-476295; O75751:SLC22A3; NbExp=2; IntAct=EBI-375543, EBI-1752674; Q9BX66:SORBS1; NbExp=2; IntAct=EBI-375543, EBI-433642; Q07890:SOS2; NbExp=2; IntAct=EBI-375543, EBI-298181; P63104:YWHAZ; NbExp=2; IntAct=EBI-375543, EBI-347088;
SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Nucleus. Mitochondrion (By similarity). Note=Shuttles between the nucleus and cytoplasm depending on environmental signals. Sequestered into the cytoplasm through interaction with 14-3-3 proteins. Localizes to mitochondria in response to oxidative stress (By similarity).
SUBCELLULAR LOCATION: Isoform IB: Nucleus membrane; Lipid-anchor. Note=The myristoylated c-ABL protein is reported to be nuclear.
TISSUE SPECIFICITY: Widely expressed.
PTM: Acetylated at Lys-711 by EP300 which promotes the cytoplasmic translocation.
PTM: Phosphorylation at Tyr-70 by members of the SRC family of kinases disrupts SH3 domain-based autoinhibitory interactions and intermolecular associations, such as that with ABI1, and also enhances kinase activity. Phosphorylation at Tyr-226 and Tyr-393 correlate with increased activity. DNA damage-induced activation of ABL1 requires the function of ATM and Ser-446 phosphorylation (By similarity). Phosphorylation at Ser-569 has been attributed to a CDC2-associated kinase and is coupled to cell division (By similarity). Phosphorylation at Ser-618 and Ser-619 by PAK2 increases binding to CRK and reduces binding to ABI1. Phosphorylation on Thr-735 is required for binding 14-3-3 proteins for cytoplasmic translocation. Phosphorylated by PRKDC (By similarity).
PTM: Polyubiquitinated. Polyubiquitination of ABL1 leads to degradation.
PTM: Isoform IB is myristoylated on Gly-2.
DISEASE: Note=A chromosomal aberration involving ABL1 is a cause of chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with BCR. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein kinase family. ABL subfamily.
SIMILARITY: Contains 1 protein kinase domain.
SIMILARITY: Contains 1 SH2 domain.
SIMILARITY: Contains 1 SH3 domain.
WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/ABL.html";
WEB RESOURCE: Name=CGP resequencing studies; URL="http://www.sanger.ac.uk/perl/genetics/CGP/cgp_viewer?action=gene&ln=ABL1";
WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/abl1/";
WEB RESOURCE: Name=Wikipedia; Note=Abl entry; URL="http://en.wikipedia.org/wiki/Abl_gene";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: ABL1
Diseases sorted by gene-association score: congenital heart defects and skeletal malformations syndrome* (900), leukemia, chronic myeloid, somatic* (215), heart disease* (200), leukemia, acute lymphoblastic 3* (118), abl1 kd-related altered drug metabolism* (100), precursor t-cell acute lymphoblastic leukemia* (94), myeloid leukemia (33), leukemia (29), myeloproliferative neoplasm (7), lymphoblastic leukemia (6), philadelphia-negative chronic myeloid leukemia (6), gastrointestinal stromal tumor (4), hypereosinophilic syndrome (4), bone marrow cancer (4), hematologic cancer (4), essential thrombocythemia (3), leukemia, acute lymphoblastic (3), childhood leukemia (2), chronic eosinophilic leukemia (2), cellular neurofibroma (2), t-cell prolymphocytic leukemia (2), myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (1), myelofibrosis with myeloid metaplasia, somatic (1), artemis deficiency (1), leukemia, acute myeloid (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 65.06 RPKM in Colon - Sigmoid
Total median expression: 1262.71 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -114.60193-0.594 Picture PostScript Text
3' UTR -779.101992-0.391 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR015015 - F-actin_binding
IPR011009 - Kinase-like_dom
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR001245 - Ser-Thr/Tyr_kinase_cat_dom
IPR000980 - SH2
IPR001452 - SH3_domain
IPR008266 - Tyr_kinase_AS
IPR020635 - Tyr_kinase_cat_dom

Pfam Domains:
PF00017 - SH2 domain
PF00018 - SH3 domain
PF00069 - Protein kinase domain
PF07653 - Variant SH3 domain
PF07714 - Protein tyrosine and serine/threonine kinase
PF08919 - F-actin binding

SCOP Domains:
50044 - SH3-domain
56112 - Protein kinase-like (PK-like)
55550 - SH2 domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1AB2 - NMR MuPIT 1ABL - Model 1AWO - NMR MuPIT 1BBZ - X-ray MuPIT 1JU5 - NMR MuPIT 1OPL - X-ray MuPIT 1ZZP - NMR MuPIT 2ABL - X-ray MuPIT 2E2B - X-ray MuPIT 2F4J - X-ray MuPIT 2FO0 - X-ray MuPIT 2G1T - X-ray MuPIT 2G2F - X-ray MuPIT 2G2H - X-ray MuPIT 2G2I - X-ray MuPIT 2GQG - X-ray MuPIT 2HIW - X-ray MuPIT 2HYY - X-ray MuPIT 2HZ0 - X-ray MuPIT 2HZ4 - X-ray MuPIT 2HZI - X-ray MuPIT 2O88 - X-ray MuPIT 2V7A - X-ray MuPIT 3CS9 - X-ray MuPIT 3EG0 - X-ray MuPIT 3EG1 - X-ray MuPIT 3EG2 - X-ray MuPIT 3EG3 - X-ray MuPIT 3EGU - X-ray MuPIT 3K2M - X-ray MuPIT 3PYY - X-ray MuPIT 3QRI - X-ray MuPIT 3QRJ - X-ray MuPIT 3QRK - X-ray MuPIT 3T04 - X-ray MuPIT 3UE4 - X-ray MuPIT 3UYO - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P00519
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details Gene Details  
Gene SorterGene Sorter Gene Sorter  
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0000287 magnesium ion binding
GO:0001784 phosphotyrosine binding
GO:0003677 DNA binding
GO:0003785 actin monomer binding
GO:0004515 nicotinate-nucleotide adenylyltransferase activity
GO:0004672 protein kinase activity
GO:0004713 protein tyrosine kinase activity
GO:0004715 non-membrane spanning protein tyrosine kinase activity
GO:0005080 protein kinase C binding
GO:0005102 receptor binding
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0008022 protein C-terminus binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0017124 SH3 domain binding
GO:0019904 protein domain specific binding
GO:0019905 syntaxin binding
GO:0030145 manganese ion binding
GO:0038191 neuropilin binding
GO:0042169 SH2 domain binding
GO:0046872 metal ion binding
GO:0046875 ephrin receptor binding
GO:0051015 actin filament binding
GO:0051019 mitogen-activated protein kinase binding
GO:0070064 proline-rich region binding

Biological Process:
GO:0000278 mitotic cell cycle
GO:0001843 neural tube closure
GO:0001922 B-1 B cell homeostasis
GO:0001934 positive regulation of protein phosphorylation
GO:0002322 B cell proliferation involved in immune response
GO:0002333 transitional one stage B cell differentiation
GO:0006281 DNA repair
GO:0006298 mismatch repair
GO:0006355 regulation of transcription, DNA-templated
GO:0006464 cellular protein modification process
GO:0006468 protein phosphorylation
GO:0006897 endocytosis
GO:0006909 phagocytosis
GO:0006914 autophagy
GO:0006915 apoptotic process
GO:0006974 cellular response to DNA damage stimulus
GO:0006975 DNA damage induced protein phosphorylation
GO:0006979 response to oxidative stress
GO:0007050 cell cycle arrest
GO:0007155 cell adhesion
GO:0007173 epidermal growth factor receptor signaling pathway
GO:0007204 positive regulation of cytosolic calcium ion concentration
GO:0007229 integrin-mediated signaling pathway
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage
GO:0009791 post-embryonic development
GO:0010506 regulation of autophagy
GO:0010595 positive regulation of endothelial cell migration
GO:0016310 phosphorylation
GO:0018108 peptidyl-tyrosine phosphorylation
GO:0021587 cerebellum morphogenesis
GO:0022408 negative regulation of cell-cell adhesion
GO:0030035 microspike assembly
GO:0030036 actin cytoskeleton organization
GO:0030100 regulation of endocytosis
GO:0030155 regulation of cell adhesion
GO:0030182 neuron differentiation
GO:0030514 negative regulation of BMP signaling pathway
GO:0030516 regulation of axon extension
GO:0031113 regulation of microtubule polymerization
GO:0032489 regulation of Cdc42 protein signal transduction
GO:0032956 regulation of actin cytoskeleton organization
GO:0033690 positive regulation of osteoblast proliferation
GO:0034446 substrate adhesion-dependent cell spreading
GO:0034599 cellular response to oxidative stress
GO:0035791 platelet-derived growth factor receptor-beta signaling pathway
GO:0038083 peptidyl-tyrosine autophosphorylation
GO:0038096 Fc-gamma receptor signaling pathway involved in phagocytosis
GO:0038189 neuropilin signaling pathway
GO:0042100 B cell proliferation
GO:0042127 regulation of cell proliferation
GO:0042770 signal transduction in response to DNA damage
GO:0043065 positive regulation of apoptotic process
GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB signaling
GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling
GO:0043542 endothelial cell migration
GO:0045087 innate immune response
GO:0045184 establishment of protein localization
GO:0045580 regulation of T cell differentiation
GO:0045930 negative regulation of mitotic cell cycle
GO:0045931 positive regulation of mitotic cell cycle
GO:0046632 alpha-beta T cell differentiation
GO:0046777 protein autophosphorylation
GO:0048008 platelet-derived growth factor receptor signaling pathway
GO:0048536 spleen development
GO:0048538 thymus development
GO:0048668 collateral sprouting
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050798 activated T cell proliferation
GO:0050853 B cell receptor signaling pathway
GO:0050885 neuromuscular process controlling balance
GO:0051149 positive regulation of muscle cell differentiation
GO:0051281 positive regulation of release of sequestered calcium ion into cytosol
GO:0051353 positive regulation of oxidoreductase activity
GO:0051444 negative regulation of ubiquitin-protein transferase activity
GO:0051496 positive regulation of stress fiber assembly
GO:0051726 regulation of cell cycle
GO:0051882 mitochondrial depolarization
GO:0051894 positive regulation of focal adhesion assembly
GO:0060020 Bergmann glial cell differentiation
GO:0060563 neuroepithelial cell differentiation
GO:0070301 cellular response to hydrogen peroxide
GO:0070373 negative regulation of ERK1 and ERK2 cascade
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0071222 cellular response to lipopolysaccharide
GO:0071901 negative regulation of protein serine/threonine kinase activity
GO:0072358 cardiovascular system development
GO:0090050 positive regulation of cell migration involved in sprouting angiogenesis
GO:0090135 actin filament branching
GO:1900026 positive regulation of substrate adhesion-dependent cell spreading
GO:1900042 positive regulation of interleukin-2 secretion
GO:1900272 negative regulation of long-term synaptic potentiation
GO:1900275 negative regulation of phospholipase C activity
GO:1901216 positive regulation of neuron death
GO:1902036 regulation of hematopoietic stem cell differentiation
GO:1902715 positive regulation of interferon-gamma secretion
GO:1903053 regulation of extracellular matrix organization
GO:1903351 cellular response to dopamine
GO:1904528 positive regulation of microtubule binding
GO:1904531 positive regulation of actin filament binding
GO:1905244 regulation of modification of synaptic structure
GO:1905555 positive regulation blood vessel branching
GO:1990051 activation of protein kinase C activity
GO:2000096 positive regulation of Wnt signaling pathway, planar cell polarity pathway
GO:2000145 regulation of cell motility
GO:2000249 regulation of actin cytoskeleton reorganization
GO:2000251 positive regulation of actin cytoskeleton reorganization
GO:2000352 negative regulation of endothelial cell apoptotic process
GO:2000772 regulation of cellular senescence
GO:2000773 negative regulation of cellular senescence
GO:2001020 regulation of response to DNA damage stimulus

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005737 cytoplasm
GO:0005739 mitochondrion
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0015629 actin cytoskeleton
GO:0016020 membrane
GO:0016604 nuclear body
GO:0030425 dendrite
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane
GO:0031252 cell leading edge
GO:0031965 nuclear membrane
GO:0032991 macromolecular complex
GO:0043025 neuronal cell body
GO:0048471 perinuclear region of cytoplasm
GO:0098794 postsynapse


-  Descriptions from all associated GenBank mRNAs
  AB209642 - Homo sapiens mRNA for Proto-oncogene tyrosine-protein kinase ABL1 variant protein.
M14753 - Human abl mRNA containing alternative first exons.
AB209456 - Homo sapiens mRNA for v-abl Abelson murine leukemia viral oncogene homolog 1 isoform b variant protein.
BC117451 - Homo sapiens c-abl oncogene 1, receptor tyrosine kinase, mRNA (cDNA clone MGC:151060 IMAGE:40126002), complete cds.
AB384952 - Synthetic construct DNA, clone: pF1KB4477, Homo sapiens ABL1 gene for proto-oncogene tyrosine-protein kinase ABL1, complete cds, without stop codon, in Flexi system.
EU447303 - Homo sapiens BCR/ABL fusion protein (BCR/ABL fusion) mRNA, partial cds.
KY284159 - Homo sapiens Bcr/Abl fusion protein e13a2 mRNA, partial cds.
EU394716 - Homo sapiens BCR/ABL e18-int1b-a2 fusion protein (BCR/ABL fusion) mRNA, exons, 2 and partial cds.
M14752 - Human c-abl gene, complete cds.
M30833 - Human abl protein mRNA, 5' end.
X16416 - Human c-abl mRNA encoding p150 protein.
M14754 - Human abl mRNA containing alternative first exons.
AY789120 - Homo sapiens BCR/ABL fusion mRNA sequence.
M14755 - Homo sapiens ABL1 protein (ABL1) mRNA, partial cds.
MH743144 - Homo sapiens BCR/ABL1 e1a2 fusion protein mRNA, partial cds.
MH401088 - Homo sapiens BCR-ABL1 p190 mRNA, partial cds.
AF113911 - Homo sapiens BCR-ABL1 e1a2 chimeric protein (BCR/ABL fusion) mRNA, partial cds.
DL225921 - METHOD AND REAGENT FOR INHIBITING THE EXPRESSION OF DISEASE RELATED GENES.
DL225922 - METHOD AND REAGENT FOR INHIBITING THE EXPRESSION OF DISEASE RELATED GENES.
MF925339 - Homo sapiens BCR/ABL e8a2 fusion mRNA, partial sequence.
EF158045 - Homo sapiens BCR/ABL p210 fusion protein (BCR/ABL fusion) mRNA, partial cds.
KU375572 - Homo sapiens BCR/ABL1 fusion protein (bcr/abl1) mRNA, partial cds.
KU705509 - Homo sapiens Bcr/Abl fusion protein (Bcr/Abl fusion) mRNA, partial cds.
KU705510 - Homo sapiens Bcr/Abl fusion protein (Bcr/Abl fusion) mRNA, partial cds.
AJ131467 - Homo sapiens partial mRNA for bcr-abl1 e13a2 chimeric protein.
EU216066 - Homo sapiens BCR/ABL fusion protein isoform X9 (BCR/ABL fusion) mRNA, complete cds.
EF423615 - Homo sapiens BCR/ABL fusion protein (BCR/ABL fusion) mRNA, partial cds.
MH401089 - Homo sapiens nonfunctional BCR-ABL1 p210 mRNA, partial sequence.
M13096 - Human chimeric bcr/c-abl fusion protein gene, exons 2-5.
M25946 - Human chronic myelocytic leukemia c-abl oncogene breakpoint cluster region (bcr) DNA, partial cds.
AJ131466 - Homo sapiens partial mRNA for bcr-abl1 e14a2 chimeric protein.
EU216071 - Homo sapiens BCR/ABL fusion protein isoform Y5 (BCR/ABL fusion) mRNA, complete cds.
EU394718 - Homo sapiens BCR/ABL e14a2 fusion protein (BCR/ABL fusion) mRNA, exons 12 through 14, a2, a3, a2 and partial cds.
AM491360 - Homo sapiens partial mRNA for bcr-abl1 e14a3 chimeric protein.
AM491361 - Homo sapiens partial mRNA for bcr-abl1 e1a3 chimeric protein.
AY043457 - Homo sapiens BCR-ABL fusion protein (BCR-ABL fusion) mRNA, partial cds.
AM491359 - Homo sapiens partial mRNA for bcr-abl1 e13a3 chimeric protein.
KY287767 - Homo sapiens BCR-ABL1 fusion protein e13a3 mRNA, partial cds.
EU216060 - Homo sapiens BCR/ABL fusion protein isoform X3 (BCR/ABL fusion) mRNA, complete cds.
DQ898314 - Homo sapiens isolate e13a4 BCR/ABL fusion protein (BCR/ABL fusion) mRNA, partial cds, alternatively spliced.
JX565024 - Homo sapiens isolate c-abl D276N c-ABL1 mRNA, partial cds.
JX565025 - Homo sapiens isolate c-abl E279A c-ABL1 mRNA, partial cds.
JF272500 - Homo sapiens isolate PTS2010 mutant BCR/ABL fusion protein mRNA, partial cds.
FJ785401 - Homo sapiens isolate RRC2008 mutant BCR/ABL fusion protein mRNA, partial cds.
AK095344 - Homo sapiens cDNA FLJ38025 fis, clone CTONG2013128.
AK294983 - Homo sapiens cDNA FLJ58117 complete cds, highly similar to Proto-oncogene tyrosine-protein kinase ABL1 (EC 2.7.10.2).
BC107069 - Homo sapiens c-abl oncogene 1, receptor tyrosine kinase, mRNA (cDNA clone IMAGE:40009788), partial cds.
BC107070 - Homo sapiens c-abl oncogene 1, receptor tyrosine kinase, mRNA (cDNA clone IMAGE:40009791), partial cds.
X51945 - H.sapiens c-abl mRNA 3'-fragment.
JD022796 - Sequence 3820 from Patent EP1572962.
JD027931 - Sequence 8955 from Patent EP1572962.
JD486266 - Sequence 467290 from Patent EP1572962.
JD346336 - Sequence 327360 from Patent EP1572962.
JD210026 - Sequence 191050 from Patent EP1572962.
JD416025 - Sequence 397049 from Patent EP1572962.
JD510645 - Sequence 491669 from Patent EP1572962.
JD423633 - Sequence 404657 from Patent EP1572962.
JD123547 - Sequence 104571 from Patent EP1572962.
JD209600 - Sequence 190624 from Patent EP1572962.
JD516697 - Sequence 497721 from Patent EP1572962.
JD070818 - Sequence 51842 from Patent EP1572962.
JD403574 - Sequence 384598 from Patent EP1572962.
JD422762 - Sequence 403786 from Patent EP1572962.
JD045485 - Sequence 26509 from Patent EP1572962.
JD426968 - Sequence 407992 from Patent EP1572962.
JD023907 - Sequence 4931 from Patent EP1572962.
JD035571 - Sequence 16595 from Patent EP1572962.
JD309915 - Sequence 290939 from Patent EP1572962.
JD187990 - Sequence 169014 from Patent EP1572962.
JD495158 - Sequence 476182 from Patent EP1572962.
JD078046 - Sequence 59070 from Patent EP1572962.
JD492322 - Sequence 473346 from Patent EP1572962.
JD415897 - Sequence 396921 from Patent EP1572962.
JD063328 - Sequence 44352 from Patent EP1572962.
JD077070 - Sequence 58094 from Patent EP1572962.
JD469811 - Sequence 450835 from Patent EP1572962.
JD437438 - Sequence 418462 from Patent EP1572962.
JD072548 - Sequence 53572 from Patent EP1572962.
JD269260 - Sequence 250284 from Patent EP1572962.
JD493853 - Sequence 474877 from Patent EP1572962.
JD456863 - Sequence 437887 from Patent EP1572962.
JD127029 - Sequence 108053 from Patent EP1572962.
JD106158 - Sequence 87182 from Patent EP1572962.
JD069263 - Sequence 50287 from Patent EP1572962.
JD487760 - Sequence 468784 from Patent EP1572962.
JD227259 - Sequence 208283 from Patent EP1572962.
JD255630 - Sequence 236654 from Patent EP1572962.
AF533988 - Homo sapiens BCRE3/ABL1A11 fusion protein (BCR/ABL1 fusion) mRNA, partial cds.
JD193841 - Sequence 174865 from Patent EP1572962.
JD128034 - Sequence 109058 from Patent EP1572962.
JD219751 - Sequence 200775 from Patent EP1572962.
JD452490 - Sequence 433514 from Patent EP1572962.
JD190905 - Sequence 171929 from Patent EP1572962.
JD136593 - Sequence 117617 from Patent EP1572962.
JD464359 - Sequence 445383 from Patent EP1572962.
MP015186 - Sequence 389 from Patent WO2019016252.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_g1Pathway - Cell Cycle: G1/S Check Point
h_arfPathway - Tumor Suppressor Arf Inhibits Ribosomal Biogenesis
h_atmPathway - ATM Signaling Pathway
h_Lis1Pathway - Lissencephaly gene (LIS1) in neuronal migration and development

Reactome (by CSHL, EBI, and GO)

Protein P00519 (Reactome details) participates in the following event(s):

R-HSA-449200 Interaction of ABL1 with CDO complex
R-HSA-1013833 Cables link CDK5 and ABL1
R-HSA-5686578 Activated ATM phosphorylates ABL1
R-HSA-448957 Interaction of p38 MAPK with JLP
R-HSA-376141 Interaction of ABL with ROBO1:SLIT2
R-HSA-2130194 ABL phosphorylates WAVEs
R-HSA-5686587 ABL1 phosphorylates RAD52
R-HSA-8956659 ABL1 phosphorylates YAP1
R-HSA-428888 Phosphorylation of ROBO1 by ABL kinase
R-HSA-428883 Recruitment of CAP to ABL
R-HSA-428885 Activation of CLASP
R-HSA-8942607 Tyrosine kinases phosphorylate Cip/Kip inhibitors bound to CDK4/6:CCND complexes
R-HSA-375170 CDO in myogenesis
R-HSA-983231 Factors involved in megakaryocyte development and platelet production
R-HSA-5693565 Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
R-HSA-428890 Role of ABL in ROBO-SLIT signaling
R-HSA-525793 Myogenesis
R-HSA-109582 Hemostasis
R-HSA-2029482 Regulation of actin dynamics for phagocytic cup formation
R-HSA-5663213 RHO GTPases Activate WASPs and WAVEs
R-HSA-5693606 DNA Double Strand Break Response
R-HSA-5685938 HDR through Single Strand Annealing (SSA)
R-HSA-8939236 RUNX1 regulates transcription of genes involved in differentiation of HSCs
R-HSA-376176 Signaling by ROBO receptors
R-HSA-1266738 Developmental Biology
R-HSA-2029480 Fcgamma receptor (FCGR) dependent phagocytosis
R-HSA-195258 RHO GTPase Effectors
R-HSA-5693532 DNA Double-Strand Break Repair
R-HSA-5693567 HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
R-HSA-8878171 Transcriptional regulation by RUNX1
R-HSA-69231 Cyclin D associated events in G1
R-HSA-422475 Axon guidance
R-HSA-168249 Innate Immune System
R-HSA-194315 Signaling by Rho GTPases
R-HSA-73894 DNA Repair
R-HSA-5693538 Homology Directed Repair
R-HSA-212436 Generic Transcription Pathway
R-HSA-69236 G1 Phase
R-HSA-168256 Immune System
R-HSA-162582 Signal Transduction
R-HSA-73857 RNA Polymerase II Transcription
R-HSA-453279 Mitotic G1-G1/S phases
R-HSA-74160 Gene expression (Transcription)
R-HSA-69278 Cell Cycle (Mitotic)
R-HSA-1640170 Cell Cycle

-  Other Names for This Gene
  Alternate Gene Symbols: A3KFJ3, ABL, ABL1_HUMAN, ENST00000318560.1, ENST00000318560.2, ENST00000318560.3, ENST00000318560.4, ENST00000318560.5, JTK7, NM_005157, P00519, Q13869, Q13870, Q16133, Q17R61, Q45F09, uc317qms.1, uc317qms.2
UCSC ID: ENST00000318560.6_7
RefSeq Accession: NM_005157.6
Protein: P00519 (aka ABL1_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.